Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017

Details for Mechanism ID: 16749
Country/Region: Ethiopia
Year: 2015
Main Partner: Columbia University
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $17,409,161 Additional Pipeline Funding: $230,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,400,000
Care: TB/HIV (HVTB) $672,805
Care: Pediatric Care and Support (PDCS) $260,000
Laboratory Infrastructure (HLAB) $277,485
Strategic Information (HVSI) $163,200
Health Systems Strengthening (OHSS) $750,000
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $179,000
Biomedical Prevention: Blood Safety (HMBL) $245,280
Testing: HIV Testing and Counseling (HVCT) $744,000
Sexual Prevention: Other Sexual Prevention (HVOP) $90,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $241,991
Treatment: Adult Treatment (HTXS) $11,500,000
Treatment: Pediatric Treatment (PDTX) $885,400
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 18,116
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 3,939
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 26,281
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 30,852
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 167,135
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 89,723
HTS_TST By Test Result: Negative 2016 309,079
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 313,991
HTS_TST Sum of Aggregated Age/Sex <15 2016 57,133
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 256,858
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 313,991
HTS_TST Sum of Test Result disaggregates 2016 313,991
HTS_TST_POS By Test Result: Positive 2016 4,912
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2016 118
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 1,191
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 1,140
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 740
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 400
PMTCT_ARV Sum of New and Current disaggregates 2016 1,140
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 1,064
PMTCT_STAT By: Known positives at entry 2016 789
PMTCT_STAT By: Number of new positives identified 2016 402
PMTCT_STAT Number of new ANC and L&D clients 2016 77,094
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 73,239
PMTCT_STAT Sum of Positives Status disaggregates 2016 1,191
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 2,357
PP_PREV Total number of people in the target population 2016 2,830
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 18,116
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 17,708
TX_CURR Age/Sex: <1 Female 2016 32
TX_CURR Age/Sex: <1 Male 2016 43
TX_CURR Age/Sex: 1-4 Female 2016 137
TX_CURR Age/Sex: 1-4 Male 2016 158
TX_CURR Age/Sex: 5-14 Female 2016 276
TX_CURR Age/Sex: 5-14 Male 2016 263
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 16,584
TX_CURR Sum of age/sex disaggregates 2016 16,584
TX_NEW By Age/Sex: <1 Female 2016 8
TX_NEW By Age/Sex: <1 Male 2016 10
TX_NEW By Age/Sex: 1-4 Female 2016 31
TX_NEW By Age/Sex: 1-4 Male 2016 41
TX_NEW By Age/Sex: 10-14 Female 2016 16
TX_NEW By Age/Sex: 10-14 Male 2016 16
TX_NEW By Age/Sex: 15-19 Female 2016 42
TX_NEW By Age/Sex: 15-19 Male 2016 15
TX_NEW By Age/Sex: 20-24 Female 2016 364
TX_NEW By Age/Sex: 20-24 Male 2016 68
TX_NEW By Age/Sex: 25-49 Female 2016 1,880
TX_NEW By Age/Sex: 25-49 Male 2016 1,037
TX_NEW By Age/Sex: 5-9 Female 2016 47
TX_NEW By Age/Sex: 5-9 Male 2016 50
TX_NEW By Age/Sex: 50+ Female 2016 41
TX_NEW By Age/Sex: 50+ Male 2016 119
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 3,785
TX_NEW Sum of Age/Sex disaggregates 2016 3,785
VMMC_AE Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) 2016 50
VMMC_CIRC By Age: 10-14 2016 3,275
VMMC_CIRC By Age: 15-19 2016 1,756
VMMC_CIRC By Age: 20-24 2016 920
VMMC_CIRC By Age: 50+ 2016 138
VMMC_CIRC By circumcision technique: Surgical VMMC 2016 10,000
VMMC_CIRC By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2016 10,000
VMMC_CIRC By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site 2016 1,998
VMMC_CIRC By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2016 7,996
VMMC_CIRC By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2016 6
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2016 10,000
VMMC_CIRC Sum of age disaggregates 2016 6,089
Cross Cutting Budget Categories and Known Amounts Total: $4,120,244
Gender: Gender Based Violence (GBV) $88,600
GBV Prevention
Implementation
Capacity building
Post GBV Care
Implementation
Capacity building
Human Resources for Health $1,772,700
Food and Nutrition: Policy, Tools, and Service Delivery $177,227
Education $177,227
Condoms: Policy, Tools, and Services $88,600
Water $88,613
Key Populations: Sex Workers $177,277
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Motor Vehicles: Purchased $550,000
Renovation $1,000,000